NASDAQ
Total Transactions
6
6 buys /0 sells
Shares Acquired
126,000
Transactions: 6•Avg: 21,000
Shares Disposed
0
Transactions: 0•Avg: 0
Net Activity
+126,000
Net Selling•Ratio: 0%
Q3 2025(Current) | 126,000 | 0 | +126,000 | 0.00% |
Q2 2025 | 56,100 | 14,100 | +42,000 | 150.00% |
Q1 2025 | 1,450,369 | 0 | +1,450,369 | 0.00% |
Q3 2024 | 1,626,400 | 0 | +1,626,400 | 0.00% |
Q2 2024 | 105,000 | 0 | +105,000 | 0.00% |
This table shows insider trading activity by quarter. A ratio > 100% indicates insiders acquired more shares than they disposed of during the period, which is generally considered a bullish signal.
• Most recent data for Q3 2025
Acquired vs Disposed Shares
Net Accumulation: 126,000 shares•Acquired/Disposed Ratio: 0%
Net Activity | |||||
|---|---|---|---|---|---|
FFML Fairmount Funds Management LLC | Director, 10 percent owner: | 12 | 2,621,156 | 41,958 | +2,579,198 |
MSF Mahoney Stephen F. | Director, officer: president and ceo | 5 | 1,794,793 | 0 | +1,794,793 |
MSD Myers Scott Dunseth | Director, officer: chief executive officer | 5 | 1,259,500 | 0 | +1,259,500 |
BTW Beetham Thomas W. | Officer: chief operating officer | 5 | 742,850 | 0 | +742,850 |
CT Ciulla Thomas | Officer: chief medical officer | 5 | 50,000 | 570,000 | -520,000 |
This table shows the trading activity of the most active company insiders. Positive net activity (buying more than selling) is often considered a bullish signal.
2025-10-23 | Director, 10 percent owner: | Purchase | 454,545 | $22 | $9,999,990 | 3,914,458 | |
2025-07-01 | Director | Purchase | 21,000 | $14.47 | $303,870 | 21,000 | |
2025-07-01 | Director | Purchase | 21,000 | $14.47 | $303,870 | 21,000 | |
2025-07-01 | Director | Purchase | 21,000 | $14.47 | $303,870 | 21,000 | |
2025-07-01 | Director | Purchase | 21,000 | $14.47 | $303,870 | 21,000 |
This table displays recent Form 4 filings showing transactions by company insiders. SEC rules require insiders to report their transactions within two business days.
FFML Fairmount Funds Management LLC | Director, 10 percent owner: | Oct 27, 2025 | |
CCW CAIN CHRISTOPHER W. | Director | Jul 2, 2025 | |
KT Kiselak Tomas | Director | Jul 2, 2025 | |
MA Morris Arlene | Director | Jul 2, 2025 | |
AJR Ajer Jeffrey Robert | Director | Jul 2, 2025 |
Net change in shares shown on right
No price data available for this timeframe.